Fluidigm, GenomOncology Partner to Create Integrated Workflow for Immuno-Oncology Research

September 8, 2018

Fluidigm and GenomOncology announced today that they have partnered to create what they’re calling the Immuno-Oncology Gene Expression Workflow, with the goal of accelerating the development of checkpoint immunotherapies and the identification of potential predictive biomarker signatures for therapeutic response.

Read more…

Welcome to ZapisCapital.com. To find out more about how we use cookies and how you can change your settings, read our privacy policy